This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] (ENGOT-EN5)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03555422
Recruitment Status : Active, not recruiting
First Posted : June 13, 2018
Last Update Posted : December 5, 2023
Belgium and Luxembourg Gynaecological Oncology Group
North-Eastern German Society of Gynaecologic Oncology
Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies
Spanish Research Group in Ovarian Cancer
The Central and Eastern European Gynecologic Oncology Group
Israel Society of Gynecologic Oncology
The GOG Foundation, Inc.
Information provided by (Responsible Party):
Karyopharm Therapeutics Inc

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2024
Estimated Study Completion Date : December 2024